Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
Paclitaxel → Fmoc-Leu PABC Paclitaxel
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | Paclitaxel | HCID 36314 | — |
| 반응물 | Fmoc-Leu PABC | HCID 131731174 | — |
| 촉매 | 4-(Dimethylamino)pyridine | HCID 14284 | — |
| 용매 | Dichloromethane | HCID 6344 | — |
| 생성물 | Fmoc-Leu PABC Paclitaxel | HCID 131731173 | 93% |
반응 단계
Paclitaxel (0.37 g, 0.44 mmol) and 4-Dimethylaminopyridine (DMAP) (0.05 g, 0.44 mmol) were added to a solution of 7 (0.27 g, 0.44 mmol) in anhydrous DCM (15 mL), and the reaction was stirred in the dark at room temperature for 24 hours. Subsequently, DCM (20 mL) was added and the reaction mixture was extracted with NaHCO3, brine and dried over sodium sulphate. The residue was purified on a silica gel column using ethyl acetate/hexane (1:1) to afford 8 (550 mg, 93%) as a white powder. ESI-MS (5 kV, MeOH): m/z (%)=1360.1 (100) [M+Na]+; HPLC (230 nm): >95%.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US08642555B2 |
| 출처 데이터셋 | uspto-grants-2014_02 |
| ORD ID | ord-baa64055c72c46edb4b6fb547eebad34 |
| 출처 메모 | uspto-grants-2014_02 |